Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.

Suppr

超能文献

作者信息

Mezger J, Calavrezos A, Drings P, Gatzemeier U, Kaukel E, Konietzko N, Koschel G, Lamerz R, von Pawel J, Römer W

出版信息

Lung. 1994;172(3):183-4. doi: 10.1007/BF00175946.

DOI:10.1007/BF00175946

PMID:8201832

Abstract

摘要

相似文献

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.

Lung. 1994;172(3):183-4. doi: 10.1007/BF00175946.

Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.

Chest. 2001 Apr;119(4):1138-42. doi: 10.1378/chest.119.4.1138.

Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.

Eur Respir J. 1995 Mar;8(3):403-6. doi: 10.1183/09031936.95.08030403.

[Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].

Wien Klin Wochenschr. 1986 Sep 12;98(17):564-73.

Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.

J Thorac Cardiovasc Surg. 1990 Dec;100(6):860-6.

Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.

Jpn J Clin Oncol. 1997 Oct;27(5):293-7. doi: 10.1093/jjco/27.5.293.

Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.

Eur J Cancer. 1993;29A(13):1806-9. doi: 10.1016/0959-8049(93)90525-k.

Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.

Chest. 1988 Nov;94(5):1037-9. doi: 10.1378/chest.94.5.1037.

Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.

Clin Biochem. 2000 Jul;33(5):405-10. doi: 10.1016/s0009-9120(00)00157-0.

[Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].

Dtsch Med Wochenschr. 1991 Feb 8;116(6):207-11. doi: 10.1055/s-2008-1063601.

引用本文的文献

Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.

Respir Res. 2020 Oct 29;21(1):284. doi: 10.1186/s12931-020-01557-z.

Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.

Ther Adv Med Oncol. 2019 May 22;11:1758835919850341. doi: 10.1177/1758835919850341. eCollection 2019.

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

Thorax. 2007 Jul;62(7):569-76. doi: 10.1136/thx.2006.068114. Epub 2007 Mar 13.

Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.

Pathol Oncol Res. 2005;11(4):236-41. doi: 10.1007/BF02893857. Epub 2005 Dec 31.

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.

Br J Cancer. 1999 Nov;81(6):1059-65. doi: 10.1038/sj.bjc.6690807.

本文引用的文献

Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.

Cancer. 1984 Mar 1;53(5):1194-7. doi: 10.1002/1097-0142(19840301)53:5<1194::aid-cncr2820530528>3.0.co;2-n.

Detection of malignant pleural effusions by tumor marker evaluation.

Eur J Cancer Clin Oncol. 1988 Jun;24(6):1005-11. doi: 10.1016/0277-5379(88)90150-2.

Malignant mesothelioma of the pleura.

Mayo Clin Proc. 1988 Dec;63(12):1234-44. doi: 10.1016/s0025-6196(12)65411-1.

Tumour associated antigens in diagnosis of serous effusions.

J Clin Pathol. 1988 Jun;41(6):633-43. doi: 10.1136/jcp.41.6.633.

Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.

J Thorac Cardiovasc Surg. 1990 Dec;100(6):860-6.

Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.

Mod Pathol. 1991 May;4(3):342-53.

[Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].

Dtsch Med Wochenschr. 1991 Feb 8;116(6):207-11. doi: 10.1055/s-2008-1063601.

New strategies are needed in diffuse malignant mesothelioma.

Cancer. 1992 Dec 15;70(12):2969-79. doi: 10.1002/1097-0142(19921215)70:12<2969::aid-cncr2820701239>3.0.co;2-a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验